A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving Sitagliptin

NCT02685345 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: DS-8500a 25 mg
DRUG: DS-8500a 75 mg
DRUG: placebo

Sponsor

Daiichi Sankyo Co., Ltd.

Collaborators

[object Object]